August 26, 2016 11:15 PM ET

Healthcare Equipment and Supplies

Company Overview of NovoCure Limited

Executive Profile

Gert Lennart Perlhagen

Director and Member of Compensation Committee, NovoCure Limited
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
73$13,125

Background

Mr. Gert Lennart Perlhagen is the Founder of Meda AB. Mr. Perlhagen served as Chief Executive Officer for Scandinavia and UK for Pfizer where Mr. Perlhagen gained extensive experience in oncology through the launch of the chemotherapy agent doxorubicin (Adriamycin). He helped lead the commercial launch of omeprazole (Losec/ Prilosec), which became the best selling pharmaceutical product in the world for AstroZeneca AB where he served as Regional Director for South Europe. ...

Corporate Headquarters

Le Masurier House
Saint Helier, Jersey JE2 4YE

Channel Islands

Phone: 44 15 3475 6700
Fax: --

Board Members Memberships

Director
2003-Present
Director and Member of Compensation Committee

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$13,125
Total Calculated Compensation$13,125
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NovoCure Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.